Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 2
2007 2
2008 2
2009 1
2010 3
2011 1
2014 1
2015 2
2016 7
2017 9
2018 9
2019 12
2020 11
2021 14
2022 14
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review.
Fionda B, Loperfido A, Di Stefani A, Lancellotta V, Paradisi A, De Angeli M, Cappilli S, Rossi E, Caretto AA, Zinicola T, Schinzari G, Gentileschi S, Morganti AG, Rembielak A, Peris K, Tagliaferri L. Fionda B, et al. Among authors: schinzari g. J Clin Med. 2024 Mar 21;13(6):1798. doi: 10.3390/jcm13061798. J Clin Med. 2024. PMID: 38542022 Free PMC article. Review.
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues.
Raia S, Chiloiro S, Giampietro A, Maratta MG, Attili F, Brizi MG, Rufini V, De Marinis L, Pontecorvi A, Rindi G, Schinzari G, Bianchi A. Raia S, et al. Among authors: schinzari g. Endocr Metab Immune Disord Drug Targets. 2024 Jan 26. doi: 10.2174/0118715303277049231229051823. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38284724
Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin Lesions.
Di Stefani A, Cappilli S, Cuffaro G, Fionda B, Pagliara MM, Paradisi A, Ricci C, Rossi E, Sammarco MG, Schinzari G, Tagliaferri L, Blasi MA, Cinotti E, Moro A, Savino G, Suppa M, Peris K. Di Stefani A, et al. Among authors: schinzari g. Diagnostics (Basel). 2023 Dec 3;13(23):3590. doi: 10.3390/diagnostics13233590. Diagnostics (Basel). 2023. PMID: 38066831 Free PMC article.
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways.
Serioli S, Agostini L, Pietrantoni A, Valeri F, Costanza F, Chiloiro S, Buffoli B, Piazza A, Poliani PL, Peris-Celda M, Iavarone F, Gaudino S, Gessi M, Schinzari G, Mattogno PP, Giampietro A, De Marinis L, Pontecorvi A, Fontanella MM, Lauretti L, Rindi G, Olivi A, Bianchi A, Doglietto F. Serioli S, et al. Among authors: schinzari g. Int J Mol Sci. 2023 Oct 29;24(21):15719. doi: 10.3390/ijms242115719. Int J Mol Sci. 2023. PMID: 37958702 Free PMC article. Review.
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
Anpalakhan S, Signori A, Cortellini A, Verzoni E, Giusti R, Aprile G, Ermacora P, Catino A, Pipitone S, Di Napoli M, Scotti V, Mazzoni F, Guglielmini PF, Veccia A, Maruzzo M, Schinzari G, Casadei C, Grossi F, Rizzo M, Montesarchio V, Verderame F, Mencoboni M, Zustovich F, Fratino L, Accettura C, Cinieri S, Tondini CA, Camerini A, Banzi MC, Sorarù M, Zucali PA, Vignani F, Ricciardi S, Russo A, Cosenza A, Di Maio M, De Giorgi U, Pignata S, Giannarelli D, Pinto C, Buti S, Fornarini G, Rebuzzi SE, Rescigno P, Addeo A, Banna GL, Bersanelli M. Anpalakhan S, et al. Among authors: schinzari g. iScience. 2023 Sep 22;26(11):107970. doi: 10.1016/j.isci.2023.107970. eCollection 2023 Nov 17. iScience. 2023. PMID: 37860695 Free PMC article.
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial.
Grimm MO, Esteban E, Barthélémy P, Schmidinger M, Busch J, Valderrama BP, Charnley N, Schmitz M, Schumacher U, Leucht K, Foller S, Baretton G, Duran I, de Velasco G, Priou F, Maroto P, Albiges L; TITAN-RCC study group. Grimm MO, et al. Lancet Oncol. 2023 Nov;24(11):1252-1265. doi: 10.1016/S1470-2045(23)00449-7. Epub 2023 Oct 13. Lancet Oncol. 2023. PMID: 37844597 Clinical Trial.
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors.
Mezi S, Pomati G, Fiscon G, Amirhassankhani S, Zizzari IG, Napoletano C, Rughetti A, Rossi E, Schinzari G, Tortora G, Lanzetta G, D'Amati G, Nuti M, Santini D, Botticelli A. Mezi S, et al. Among authors: schinzari g. Front Immunol. 2023 Jul 7;14:1199089. doi: 10.3389/fimmu.2023.1199089. eCollection 2023. Front Immunol. 2023. PMID: 37483633 Free PMC article.
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience.
Borrelli de Andreis F, Boškoski I, Mascagni P, Schepis T, Bianchi A, Schinzari G, Annicchiarico BE, Quero G, Tortora G, Alfieri S, Gasbarrini A, Costamagna G, Spada C, Attili F. Borrelli de Andreis F, et al. Among authors: schinzari g. Pancreatology. 2023 Aug;23(5):543-549. doi: 10.1016/j.pan.2023.05.004. Epub 2023 May 22. Pancreatology. 2023. PMID: 37236853 Free article.
97 results